VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Trends Analyst Outlook Journalist View
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$33
53% upside
High target

5 analyst ratings

4  positive
80%
1  neutral
20%
0  negative
0%
Analyst & Firm Rating Price Target Upside
Downside 		Date
Goldman Sachs
Goldman Sachs
Richard Law
100% 1-yr win rate
7 Aug ‘25 2 months ago
RBC Capital
RBC Capital
Lisa Walter
100% 1-yr win rate
7 Aug ‘25 2 months ago
Wells Fargo
Wells Fargo
Derek Archila
7 Aug ‘25 2 months ago
Oppenheimer
Oppenheimer
Leland Gershell
100% 1-yr win rate
7 Aug ‘25 2 months ago
Needham
Needham
Serge Belanger
43% 1-yr win rate
6 Aug ‘25 2 months ago